The expansion comes on the heels of the company's opening of a brick-and-mortar clinic in Plano, Texas, and virtually throughout the state late last year.
The company will use the funds to scale its technology, expand into new biomarker applications, and advance real-time hydration and metabolic health monitoring.
Two U.S. senators and the Partnership for Safe Medicines sent letters to the FDA, raising concerns that the ad fails to disclose safety and side effect information required in pharmaceutical advertising.
The funds will help in the development of Northernmost's NoMo tech-enabled kidney pump, which the NKF says may eliminate the need for ice coolers completely.